TMPRSS2 and prostate carcinoma: These factors collectively contributed to unfavorable outcomes.[10] The presence of androgen, as well as the activation of androgen receptor signaling, a characteristic feature of prostate cancer, can exacerbate the severity of COVID-19 by enhancing the expression of TMPRSS2.[28–31]